NCT06312254View on ClinicalTrials.gov

Pharmacological Modulation of Peripheral Nerve Excitability

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

April 9, 2024

Primary Completion Date

December 2, 2024

Study Completion Date

December 11, 2024

Conditions
Peripheral Neuropathy
Interventions
DRUG

Topical lidocaine 5%

Drug is used to pharmacologically modulate peripheral sensory afferents

DRUG

Topical Phenytoin 10%

Drug is used to pharmacologically modulate peripheral sensory afferents

DRUG

Topical Mepyramine 2%

Drug is used to pharmacologically modulate peripheral sensory afferents

OTHER

Topical Placebo

Drug is used as control

Trial Locations (1)

Unknown

Center for Neuroplasticity and Pain, Aalborg

All Listed Sponsors
lead

Aalborg University

OTHER

NCT06312254 - Pharmacological Modulation of Peripheral Nerve Excitability | Biotech Hunter | Biotech Hunter